Frequent Facial BBCs Announcement

Aug. 27, 2020 / Ameriderm Research

Ameriderm Research continues its recruitment of patients 18-75 years of age who have frequent facial Basal Cell Carcinomas (BCCs) but do NOT have Gorlin Syndrome (Basal Cell Carcinoma Nevus Syndrome) The study involves testing a new topical medication to determine its ability to decrease the number of surgical procedures that are needed to treat and control and condition.

The trial enrollment is nearly complete, but a few openings remain.  
CALL TODAY (386) 523-0768 to see if you qualify.

Join Clinical Trial

Posted in